Scientists have uncovered a novel mechanism linking soluble amyloid b protein with the synaptic injury and memory loss associated with Alzheimer’s disease (AD). The research provides critical new insight into disease pathogenesis and reveals signaling molecules that may serve as potential additional therapeutic targets for AD.